Brief: Guard Therapeutics Obtains Granted Patent From USPTO Concerning ROSgard As Product

Disruptive Pharma AB (publ)

07/04/2021 07:46

April 7 (Reuters) - Guard Therapeutics International AB
(publ)  GUARD.ST :
    * GUARD THERAPEUTICS OBTAINS A GRANTED PATENT FROM USPTO
CONCERNING ROSGARD AS PRODUCT
    * UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
GRANTED
COMPANY'S PATENT APPLICATION NO. 16/085,500 DIRECTED TO
BIOLOGICAL INVESTIGATIONAL DRUG ROSGARD AS PRODUCT (COMPOSITION
OF MATTER)
    * GRANTED PATENT FOLLOWS NOTICE OF ALLOWANCE THAT WAS ISSUED
AND
COMMUNICATED IN DECEMBER 2020.
    * PATENT, WHICH PROVIDES PROTECTION UNTIL 2037, ALSO COVERS
RELATED MOLECULES THAT ARE OF SIMILAR STRUCTURE TO ROSGARD.

Source text for Eikon:  ID:nMFN8rpCwP 
Further company coverage:  GUARD.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))